Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
12/1999
12/02/1999CA2333159A1 Method
12/02/1999CA2330611A1 Bifunctional molecules and therapies based thereon
12/02/1999CA2329159A1 Compositions and methods for the synthesis of fatty acids, their derivatives and downstream products
12/02/1999CA2329157A1 Inhibition of the binding of protein tyrosine phosphatase pest to domains of signalling proteins
12/02/1999CA2329156A1 Genes encoding epsilon lycopene cyclase and method for producing bicyclic epsilon carotene
12/02/1999CA2329124A1 Sphingosine kinase, cloning, expression and methods of use
12/02/1999CA2329076A1 Human hydrolase homologs: n-terminal asparagine amidohydrolase, glycosyl hydrolase, glucohydrolase, biotinidase, and n-acetylglucosamine 6-p deacetylase
12/02/1999CA2328471A1 Polyhydroxyalkanoate biopolymer compositions
12/02/1999CA2328427A1 Recombinant narbonolide polyketide synthase
12/02/1999CA2327541A1 Compositions and methods for inhibiting endothelial cell proliferation and regulating angiogenesis using serine proteases
12/02/1999CA2325462A1 Novel nucleic acids and polypeptides related to a farnesyl-directed endopeptidase
12/02/1999CA2234420A1 Methods for the detection, treatment, and prevention of neurodegeneration
12/01/1999EP0960941A1 Gene Therapy for cell proliferative diseases
12/01/1999EP0960939A2 Dual-tagged proteins and their uses
12/01/1999EP0960938A1 Novel serine-threonine kinase gene
12/01/1999EP0960934A1 Novel phytase and process for the preparation thereof
12/01/1999EP0960337A1 Cathepsin K and breast cancer
12/01/1999EP0960211A1 Compositions and methods for the identification and treatment of patients at risk for heart failure
12/01/1999EP0960208A1 Glutathione s-transferase (gst) genes in cancer
12/01/1999EP0960204A1 Method and reagents for genetic immunization
12/01/1999EP0960203A1 Mammalian chk1 effector cell-cycle checkpoint protein kinase materials and methods
12/01/1999EP0960197A1 GENES FROM 20q13 AMPLICON AND THEIR USES
12/01/1999EP0960193A1 ISOLATION AND CLONING OF THE HUMAN hARSA-I GENE AND USES THEREOF
12/01/1999EP0960192A1 Synthetic polynucleotides
12/01/1999EP0960190A1 Imidazolinone herbicide resistant sugar beet plants
12/01/1999EP0960127A1 Isolated dimeric fibroblast activation protein alpha, and uses thereof
12/01/1999EP0959903A1 NOVEL FabD
12/01/1999EP0959691A1 Method and apparatus for processing krill hydrolysates
12/01/1999EP0784706B1 A method for processing of hides or skins into leather, comprising enzymatic treatment of the hide or skin with a trypsin acting microbial protease
12/01/1999EP0665892B1 Enhanced indole biosynthesis
12/01/1999CN1237208A Method and material for candida utilis transformation
12/01/1999CN1237207A Chrysosporium cellulase and methods of use
12/01/1999CN1237206A Genes encoding proteins having transglycosylation activity
12/01/1999CN1237205A Enhanced expression of proteolytic enzymes in koji mold
12/01/1999CN1237204A High molecular weight trichoderma cellulase
12/01/1999CN1237200A Cellulase obtainable from thermomonospora fusca for use in industrial processes
11/1999
11/30/1999US5994629 Positive selection
11/30/1999US5994625 Obtaining a plant host which contains a chimeric expressible antifungal chitin binding protein gene.
11/30/1999US5994623 Pertains to nucleic acid fragments encoding enzymes involved in starch biosynthesis in corn plants and seeds.
11/30/1999US5994616 Targeted synthesis of protein in mammary gland of a non-human transgenic mammal
11/30/1999US5994519 Labelling proteins, peptides, or ligands by binding first marker ligand-enzyme conjugate to a specific binding pair member; binding label molecules to proteins, peptides, or ligands; isolating and/or purifying labelled product
11/30/1999US5994513 Oncoprotein protein kinase
11/30/1999US5994503 Nucleotide and protein sequences of lats genes and methods based thereon
11/30/1999US5994381 Antipyretics; antiinflammatory agents; analgesics
11/30/1999US5994339 Oxidant scavengers
11/30/1999US5994309 Anti-invasive and anti-angiogenic compositions and methods
11/30/1999US5994301 Corpuscles of stannius protein, stanniocalcin
11/30/1999US5994119 Mammalian regulator of nonsense-mediated RNA decay
11/30/1999US5994114 A polynucleotide which codes for a protein having taxadiene synthase activity; chemotherapy
11/30/1999US5994113 Enzymes with aminopeptidase activity
11/30/1999US5994112 A polynucleotide which codes a protein; antiproliferative agents, anticarcinogenic agents, antiinflammatory agents
11/30/1999US5994111 A polypeptide; treatment and diagnosis of respiratory infections, septic arthritis, cardiovascular infections, gastrointestinal infections, toxic shock syndrome; antibiotics
11/30/1999US5994105 A polypeptide having an amino acid sequence having acylglucosamine 2-epimerase activity; antihypertensive agent
11/30/1999US5994100 HAS2 splicing variant HOEFC11: a target in chronic renal failure, inflammatory diseases and myocardial ischemia
11/30/1999US5994084 A cell that enodgenously expresses the protein tau and having a gene encoding a kinase that modulates phosphorylation of the protein tau; cultured cell exhibited hyperphosphorylation of tau and neurofibrillary tangles; preventing alzheimer's
11/30/1999US5994082 Methods for the identification of inhibitors which suppress the activity of proteins displaying CIITA activity
11/30/1999US5994074 Determining and regulating expression of tyrosine phosphatase gene in cells, detecting messenger rna using oligonucleotide probes; regulating the cell cycle through altering the activity or levels of tyrosine phosphatases
11/30/1999US5994070 A nucleic acid and polypeptide which regulates a variety of cellular processes; diagnosis and treatment of nervous sytem disorders; alzheimer's/huntinton's/parkinson's diseases
11/30/1999US5994069 Forming nucleic acid cleavage structure on target sequence and cleaving the nucleic acid in a site specific manner using structure specific 5'nucleases then annealing complementary oligonucleotides to detect target nucleic acid
11/30/1999US5993889 Trehalose phosphorylase, its preparation and use
11/30/1999US5993808 Chitinase, DNA coding therefor and plants containing same
11/30/1999US5993807 Truncated aspartase enzyme derivatives and uses thereof
11/30/1999US5993799 Methods of using genetically engineered cells that produce insulin in response to glucose
11/30/1999CA2154178C Plants resistant to infection by plrv
11/30/1999CA1340831C Ribozymes
11/30/1999CA1340830C Process for production of physiologically active peptide containing cysteine residue
11/29/1999CA2273173A1 Extension of lifespan by overexpression of a gene that increases reactive oxygen metabolism
11/25/1999WO1999060168A1 Method and apparatus for activating a thermo-enzyme reaction with electromagnetic energy
11/25/1999WO1999060152A1 Process for sialylating glycoproteins
11/25/1999WO1999060142A2 Gene therapy vectors and their use in antitumour therapy
11/25/1999WO1999060139A1 ENZYMATICALLY-ACTIVE RECOMBINANT HUMAN β-TRYPTASE AND METHOD OF MAKING SAME
11/25/1999WO1999060138A2 Regulated expression of pkc and/or srb1/psa1 in yeast
11/25/1999WO1999060137A2 Methods for producing heterologous polypeptides in trichothecene-deficient filamentous fungal mutant cells
11/25/1999WO1999060136A1 Methods for producing polypeptides in filamentous fungal mutant cells
11/25/1999WO1999060134A1 New peptide fragments for protein purification
11/25/1999WO1999060133A2 Human nucleic acid methylases
11/25/1999WO1999060108A2 Transgenic animals produced by homologous sequence targeting
11/25/1999WO1999060107A2 Nicotianamine synthase genes, isolation and use thereof
11/25/1999WO1999060104A1 Novel glutaminase, gene thereof and process for producing the same
11/25/1999WO1999060103A2 Galactosyltransferase from plants involved in galactomannan biosynthrsis
11/25/1999WO1999060102A2 Improved in vivo production of cephalosporins
11/25/1999WO1999060100A1 Irak modified transgenic animals
11/25/1999WO1999060097A1 clpX OF $i(STREPTOCOCCUS PNEUMONIAE)
11/25/1999WO1999060096A2 Oxygenase enzymes and screening method
11/25/1999WO1999060008A1 Cytosine deaminase gene
11/25/1999WO1999059620A1 Angiostatin receptor
11/25/1999WO1999059611A1 Compositions and methods for prevention and treatment of uncontrolled formation of intravascular fibrin clots
11/25/1999WO1999059559A1 Independent regulation of basal and insulin-stimulated glucose transport
11/25/1999WO1999049020A3 Phenol oxidizing enzyme enzymes
11/25/1999WO1999047656A3 Nucleic acid binding proteins
11/25/1999WO1999043835A3 Methods for producing a polypeptide in a bacillus cell
11/25/1999WO1999043832A3 Human proteinase molecules
11/25/1999WO1999041390A3 Expression vector for the production of dead proteins
11/25/1999WO1999037766A3 A purified polynucleotide sequence containing a region encoding a mutated zap-70 protein or a fragment thereof
11/25/1999WO1999035271A3 Vibrio cholerae vaccine candidates and method of their constructing
11/25/1999WO1999034001A3 Proteases from gram positive organisms
11/25/1999WO1999033959A3 Proteases from gram positive organisms
11/25/1999WO1999031969A3 Transgenic animal model for degenerative diseases of cartilage
11/25/1999WO1999021880A3 Plant branched-chain amino acid biosynthetic enzymes
11/25/1999DE19824307A1 DNA encoding nicotinamine synthase from barley and tomato